Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPREOMYCIN for Pulmonary tuberculosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 82 adverse event reports in the FDA FAERS database where CAPREOMYCIN was used for Pulmonary tuberculosis.

Most Reported Side Effects for CAPREOMYCIN

Side Effect Reports % Deaths Hosp.
Electrocardiogram qt prolonged 74 18.6% 15 28
Off label use 53 13.3% 15 17
Drug resistance 49 12.3% 8 6
Vomiting 34 8.5% 4 17
Anaemia 29 7.3% 5 9
Neuropathy peripheral 28 7.0% 5 8
Hepatotoxicity 27 6.8% 1 6
Intentional product use issue 24 6.0% 11 8
Nausea 24 6.0% 3 9
Dyspnoea 22 5.5% 13 13
Product use in unapproved indication 22 5.5% 3 7
Hypokalaemia 19 4.8% 5 10
Tuberculosis 19 4.8% 12 2
Gastrointestinal disorder 18 4.5% 5 7
Treatment failure 18 4.5% 8 6

Other Indications for CAPREOMYCIN

Tuberculosis (284) Lymph node tuberculosis (7) Product used for unknown indication (6) Meningitis tuberculous (5)

Other Drugs Used for Pulmonary tuberculosis

ISONIAZID (1,249) RIFAMPIN (1,192) PYRAZINAMIDE (1,134) ETHAMBUTOL (1,073) LINEZOLID (905) BEDAQUILINE (615) CLOFAZIMINE (473) MOXIFLOXACIN (413) DELAMANID (408) LEVOFLOXACIN (394)

Related Pages

CAPREOMYCIN Full Profile All Pulmonary tuberculosis Drugs CAPREOMYCIN Demographics CAPREOMYCIN Timeline